Hepatitis C virus--cell interactions and their role in pathogenesis.

In summary, HCV-cell interactions include those directly involved with the HCV life cycle such as virus attachment, entry, and replication. Included within this broad area of research are the interactions of HCV proteins with the IFN system, cytokine and chemokine pathways such as IL-8, and various other cellular proteins and pathways. The plethora of contradictory and sometimes confusing accessory HCV-host interactions defies precise predictions of their role in HCV biology. It is clear that these virus-cell interactions affect HCV replication, antiviral resistance, persistence, and pathogenesis. Because HCV-host interactions are initiated immediately on infection, they are operative during acute HCV infection, whereby HCV interacts with innate cellular antiviral and immune systems. The magnitude and duration of these HCV-host interactions therefore may influence the development of acquired immunity. Because HCV exists as a quasispecies in all infected individuals, heterogeneity in biological responses to HCV-host interactions is predicted, revealing opportunities for the development of various genotypic and phenotypic prognostic indicators. With the model systems in place, these hypotheses can be tested. The challenge for the future is to determine if there is a hierarchical importance to these interactions, to delineate how these virus-cell interactions affect the patient infected with HCV, and to determine whether any of these interactions represents a target for therapeutic intervention.

[1]  H. Thomas,et al.  Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. , 1999, Gastroenterology.

[2]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[3]  M. Katze,et al.  Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase , 1999, Journal of Virology.

[4]  D. Pessayre,et al.  Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  David E. Misek,et al.  An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. , 2002, Virology.

[6]  K. Tsuchihara,et al.  Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli , 2001, Hepatology.

[7]  M. Lai,et al.  Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor , 1997, Journal of virology.

[8]  C. Tiribelli,et al.  Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery. , 2000, Microbes and infection.

[9]  S. Polyak,et al.  Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon‐sensitive virus replication , 1999, Hepatology.

[10]  K. Lindsay Therapy of hepatitis C: Overview , 1997, Hepatology.

[11]  M. Houghton,et al.  Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. , 1993, The Journal of general virology.

[12]  G. Pasero,et al.  Infection of Peripheral Blood Mononuclear Cells by Hepatitis C Virus in Mixed Cryoglobulinemia , 1993 .

[13]  M. Honda,et al.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.

[14]  Y. Matsuura,et al.  Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  M. Levrero,et al.  Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein , 2001, Oncogene.

[16]  R. Thomssen,et al.  Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.

[17]  C. Rice,et al.  The NS5A/NS5 Proteins of Viruses from Three Genera of the Family Flaviviridae Are Phosphorylated by Associated Serine/Threonine Kinases , 1998, Journal of Virology.

[18]  M. Gerotto,et al.  The molecular basis for responsiveness to anti-viral therapy in hepatitis C. , 2000, Forum.

[19]  K. Meyer,et al.  Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death , 2000 .

[20]  M. Katze,et al.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Migliaccio,et al.  Biosynthesis and biochemical properties of the hepatitis C virus core protein , 1994, Journal of virology.

[22]  R. Eisenberg,et al.  Three classes of cell surface receptors for alphaherpesvirus entry. , 2000, Virology.

[23]  L. Beretta,et al.  Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein , 2001, Oncogene.

[24]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[25]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[26]  S. Levy,et al.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. , 2002, The Journal of clinical investigation.

[27]  R. Aebersold,et al.  Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. , 2000, Virology.

[28]  N. Mukaida Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. , 2000, International journal of hematology.

[29]  A. Siddiqui,et al.  Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Silverman 2-5A-Dependent RNase L: A Regulated Endoribonuclease in the Interferon System , 1997 .

[31]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[32]  S. Polyak,et al.  Characterization of Pichinde virus infection of cells of the monocytic lineage , 1991, Journal of virology.

[33]  M. Lai,et al.  An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. , 1999, Virology.

[34]  G. Davis,et al.  Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C , 1998, Hepatology.

[35]  B. Williams,et al.  Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  S. Fields,et al.  Hepatitis C Virus 3′X Region Interacts with Human Ribosomal Proteins , 2001, Journal of Virology.

[37]  O. Jaillon,et al.  Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. , 1998, The Journal of general virology.

[38]  S. Yap,et al.  Hepatitis C virus‐RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: Evidence for viral replication in peripheral blood mononuclear cells , 1994, Journal of medical virology.

[39]  P. Bouffard,et al.  Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. , 1992, The Journal of infectious diseases.

[40]  T. Asselah,et al.  Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C. , 2001, Clinical biochemistry.

[41]  R. De Francesco,et al.  Hyperphosphorylation of the Hepatitis C Virus NS5A Protein Requires an Active NS3 Protease, NS4A, NS4B, and NS5A Encoded on the Same Polyprotein , 1999, Journal of Virology.

[42]  C. Rice,et al.  The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. , 2001, Virology.

[43]  R. Purcell,et al.  The hepatitis C virus: Overview , 1997, Hepatology.

[44]  R. Silverman,et al.  Stress responses: Translational control perks up , 1999, Nature.

[45]  C. Rice,et al.  Efficient initiation of HCV RNA replication in cell culture. , 2000, Science.

[46]  Volker Brass,et al.  An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* , 2002, The Journal of Biological Chemistry.

[47]  S. Ray,et al.  Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy , 2000, Journal of Virology.

[48]  B. Williams,et al.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.

[49]  P. Borrow,et al.  Mechanism of lymphocytic choriomeningitis virus entry into cells. , 1994, Virology.

[50]  R. Bartenschlager,et al.  Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation , 2001, Journal of Virology.

[51]  J. Rakela,et al.  The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[52]  O. Hino,et al.  Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α , 2000 .

[53]  M. Alter,et al.  Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.

[54]  K. Shimotohno,et al.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A , 1995, Journal of virology.

[55]  J. Dubuisson,et al.  Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines , 2002, Journal of Virology.

[56]  V. Carreño,et al.  Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells. , 1993, Journal of hepatology.

[57]  Hua-Lin Wu,et al.  Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva , 1993, Journal of medical virology.

[58]  C. Rice,et al.  Identification of the Major Phosphorylation Site of the Hepatitis C Virus H Strain NS5A Protein as Serine 2321* , 1999, The Journal of Biological Chemistry.

[59]  S. Schwartz,et al.  The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3' untranslated region. , 1999, Journal of human virology.

[60]  N. Kato,et al.  Activation of the Interferon-Inducible 2′-5′-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein , 2000, Journal of Virology.

[61]  Michael G. Katze,et al.  Regulation of mRNA Translation and Cellular Signaling by Hepatitis C Virus Nonstructural Protein NS5A , 2001, Journal of Virology.

[62]  A. Meola,et al.  Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection , 2000, Journal of Virology.

[63]  K. Shimotohno,et al.  The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation , 1997, Journal of virology.

[64]  H. Blum,et al.  Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway , 1999, Journal of Virology.

[65]  C. Rice,et al.  Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins , 1998, Hepatology.

[66]  E. Schiff,et al.  A randomized, double‐blind trial comparing pegylated interferon alfa‐2b to interferon alfa‐2b as initial treatment for chronic hepatitis C , 2001, Hepatology.

[67]  Samir K. Gupta,et al.  A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .

[68]  T. Nowak,et al.  Description of a procedure which allows isolation of viral nonstructural proteins from BHK vertebrate cells infected with the West Nile flavivirus in a state which allows their direct chemical characterization. , 1990, Virology.

[69]  O. Haller,et al.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.

[70]  P. J. Wright,et al.  The sensitivity of cell-associated dengue virus proteins to trypsin and the detection of trypsin-resistant fragments of the nonstructural glycoprotein NS1. , 1991, Virology.

[71]  K. Shimotohno,et al.  Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. , 1994, Biochemical and biophysical research communications.

[72]  Kyu-Jin Park,et al.  Nonstructural 5A Protein of Hepatitis C Virus Modulates Tumor Necrosis Factor α-stimulated Nuclear Factor κB Activation* , 2002, The Journal of Biological Chemistry.

[73]  K. Tsuchihara,et al.  Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. , 1999, Virology.

[74]  A. Helenius,et al.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. , 1982, The Journal of general virology.

[75]  K Koike,et al.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.

[76]  D. S. Chen,et al.  Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. , 1992, The Journal of infectious diseases.

[77]  B. Aggarwal,et al.  Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein* , 1998, The Journal of Biological Chemistry.

[78]  G. Duverlie,et al.  Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis , 2000, Journal of Virology.

[79]  V. Agnello,et al.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  M. Lai,et al.  Hepatitis C virus core protein: possible roles in viral pathogenesis. , 2000, Current topics in microbiology and immunology.

[81]  P. Marcellin,et al.  Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. , 1999, Journal of hepatology.

[82]  Y. Sasaguri,et al.  Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-α catalytic subunit , 1997 .

[83]  M. Katze,et al.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.

[84]  M. Lai Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. , 2002, Gastroenterology.

[85]  C. Tseng,et al.  Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.

[86]  R. Bartenschlager,et al.  Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations , 2001, Journal of Virology.

[87]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[88]  Michael G. Katze,et al.  Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.

[89]  Philip Beineke,et al.  Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response , 2001, Journal of medical virology.

[90]  N. Bishop Examination of Potential Inhibitors of Hepatitis A Virus Uncoating , 1999, Intervirology.

[91]  J. Choe,et al.  Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. , 1999, Biochemical and biophysical research communications.

[92]  S. Kaneko,et al.  Hepatitis C Virus (HCV) NS5A Binds RNA-dependent RNA Polymerase (RdRP) NS5B and Modulates RNA-dependent RNA Polymerase Activity* , 2002, The Journal of Biological Chemistry.

[93]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[94]  M. Lai,et al.  Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome , 1997, Journal of virology.

[95]  K. Matsushima,et al.  Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. , 1997, Biochemical and biophysical research communications.

[96]  K. Khabar,et al.  Elevated Levels of Interleukin-8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy , 2001, Journal of Virology.

[97]  N. Enomoto,et al.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.

[98]  D. Stump,et al.  Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. , 2001, RNA.

[99]  N. Kato,et al.  Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. , 1999, Virology.

[100]  P. Marcellin,et al.  Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. , 1998, Clinical biochemistry.

[101]  K. Shimotohno,et al.  Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-κB Activation , 1999, Journal of Virology.

[102]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[103]  P. Marcellin,et al.  Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus , 1998, The Lancet.

[104]  P. Spear,et al.  Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. , 2001, The Journal of clinical investigation.

[105]  D. Fabbro,et al.  The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. , 1999, Cancer research.

[106]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[107]  T. Liang,et al.  Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. , 2001, Gastroenterology.

[108]  G. Barber,et al.  Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin-8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response , 2001, Journal of Virology.

[109]  A. Hughes,et al.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.

[110]  S. Nuti,et al.  Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co‐stimulatory signal for human T cells , 2001, European journal of immunology.

[111]  J. Prieto,et al.  Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy. , 1992, Journal of hepatology.

[112]  V. Stollar,et al.  Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. , 1990, The Journal of general virology.

[113]  K. Meyer,et al.  Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. , 2000, Virology.

[114]  W. Hong,et al.  The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. , 2001, Virology.

[115]  M. Lai,et al.  Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis , 1998, Journal of Virology.

[116]  S. Emerson,et al.  Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. , 2000, Virology.

[117]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[118]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[119]  B. Ahn,et al.  Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. , 2002, Virology.

[120]  K. Meyer,et al.  Suppression of apoptotic cell death by hepatitis C virus core protein. , 1996, Virology.

[121]  H. Handa,et al.  Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. , 2000, Virology.

[122]  William M. Lee,et al.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.

[123]  M. Lai,et al.  Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. , 2002, Virology.

[124]  J. Dubuisson Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. , 2000, Current topics in microbiology and immunology.

[125]  D. R. Taylor,et al.  Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. , 1999, Virology.

[126]  J. Hoefs,et al.  Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.

[127]  Ralf Bartenschlager,et al.  Modulation of Hepatitis C Virus NS5A Hyperphosphorylation by Nonstructural Proteins NS3, NS4A, and NS4B , 1999, Journal of Virology.

[128]  O. Laeyendecker,et al.  Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.

[129]  Y. Matsuura,et al.  Molecular basis of subcellular localization of HCV core protein. , 2008, Liver.

[130]  R. Silverman,et al.  Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.

[131]  William M. Lee,et al.  Efficacy and safety of pegylated (40‐kd) interferon α‐2a compared with interferon α‐2a in noncirrhotic patients with chronic hepatitis C , 2001 .

[132]  M. Katze,et al.  Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.

[133]  Y. Sasaguri,et al.  Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. , 1996, Gene.

[134]  A. Thiele,et al.  Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.

[135]  Frank Scholle,et al.  Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.

[136]  A. Bisceglie Liver transplantation for hepatitis C: The promise and the challenge , 1995 .

[137]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[138]  A. Gabrielli,et al.  Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia , 1994, Clinical and experimental immunology.

[139]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[140]  Y. Sasaguri,et al.  Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A* , 2001, The Journal of Biological Chemistry.

[141]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[142]  F. Sicheri,et al.  Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. , 2001, Virology.

[143]  S. Kaneko,et al.  Hepatitis C Virus NS5A Binds RNA-Dependent RNA polymerase NS5B and modulates RdRP activity , 2003 .

[144]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[145]  H. Hotta,et al.  The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. , 1999, The Journal of general virology.

[146]  M. Kohara,et al.  Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[147]  C. Rice,et al.  Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase , 1997, Journal of virology.

[148]  M. Loriot,et al.  Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice , 1998, Hepatology.

[149]  L. Ferrell,et al.  Hepatitis C viral infection in liver transplant recipients , 1992, Hepatology.

[150]  Y. Shirota,et al.  Mutational analysis of the structure and functions of hepatitis C virus RNA–dependent RNA polymerase , 2001, Hepatology.

[151]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.